CCDM ACTUAL EXAM QUESTIONS AND
COMPLETE STUDY GUIDE 2026
▶ Checklist. Answer: (ASQ) A tool used to ensure all important steps or
actions in an operation have been taken.
▶ Clinical Laboratory Improvement Amendments (CLIA). Answer: Passed
in 1988; establishes quality standards for all laboratory testing; ensures the
accuracy, reliability, and timeliness of patient test results, regardless of
where the test is performed
▶ Clinical Trial/Study. Answer: An investigation using human subjects
intended to discover or verify clinical, pharmalogical, or pharmacodynamic
effects of an investigational product or to identify AEs and/or to study
absorption, distribution, metabolism, and excretion of an investigational
product for the purpose of ascertaining its safety and/efficacy.
▶ Clinical Trial/Study Report. Answer: A written description of a trial/study
of any therapeutic, prophylactic, or diagnostic agent conducted in human
subjects, in which the clinical and statistical description, presentations, and
analyses are fully integrated into a single report.
▶ Code Libraries. Answer: A repository of validated programming logic
that can be used in the collection, review or analysis of clinical trial data.
▶ Common Causes. Answer: Causes of variation that are inherent in a
process over time. They affect every outcome of the process and everyone
working in the process.
▶ Comparator. Answer: An investigational or marketed product (active
control), or placebo, used as a reference in a clinical trial.
▶ Complience. Answer: Adherence to all trial-related requirements, GCP
requirements, and the applicable regulatory requirements.
, ▶ Composite Endpoint. Answer: Overall outcome that the protocol is
designed to evaluate based on more than one common endpoint such as
MI plus repeat intervention.
▶ Compound. Answer: A chemical molecule with potential
pharmacological activity.
▶ Confidentiality. Answer: Prevention of disclosure of a sponsor's
proprietary information or of a subject's identity to unauthorized individuals.
▶ Conformance. Answer: An affirmative indication or judgement that a
product or service has met the requirements of a relevant specification,
contract, or regulation.
▶ Contract. Answer: A written, dated, and signed agreement that sets out
any arrangements on delegation and distribution of tasks and obligations
and, if appropriate, on financial matters between two or more parties.
Protocol may serve as the basis of a contract.
▶ Coordinating Committee. Answer: A committee that a sponsor may
organize to coordinate the conduct of a multi center trial.
▶ Coordinating Investigator. Answer: An investigator assigned the
responsibility for the coordination of investigators at different centers
participating in a multicenter trial.
▶ Contract Research Organization (CRO). Answer: A person or an
organization (commercial, academic, or other) contracted by the sponsor to
perform one or more of a sponsor's trial-related duties and functions.
▶ Control Chart. Answer: A chart with upper and lower control limits on
which values of some statistical measure for a series of samples or
subgroups are plotted. The chart frequently shows a central line to help
detect a trend of plotted values toward either control limit.
▶ Corrective Action. Answer: The implementation of solutions resulting in
the reduction or elimination of an identified problem.
▶ CS. Answer: Clinically Significant
COMPLETE STUDY GUIDE 2026
▶ Checklist. Answer: (ASQ) A tool used to ensure all important steps or
actions in an operation have been taken.
▶ Clinical Laboratory Improvement Amendments (CLIA). Answer: Passed
in 1988; establishes quality standards for all laboratory testing; ensures the
accuracy, reliability, and timeliness of patient test results, regardless of
where the test is performed
▶ Clinical Trial/Study. Answer: An investigation using human subjects
intended to discover or verify clinical, pharmalogical, or pharmacodynamic
effects of an investigational product or to identify AEs and/or to study
absorption, distribution, metabolism, and excretion of an investigational
product for the purpose of ascertaining its safety and/efficacy.
▶ Clinical Trial/Study Report. Answer: A written description of a trial/study
of any therapeutic, prophylactic, or diagnostic agent conducted in human
subjects, in which the clinical and statistical description, presentations, and
analyses are fully integrated into a single report.
▶ Code Libraries. Answer: A repository of validated programming logic
that can be used in the collection, review or analysis of clinical trial data.
▶ Common Causes. Answer: Causes of variation that are inherent in a
process over time. They affect every outcome of the process and everyone
working in the process.
▶ Comparator. Answer: An investigational or marketed product (active
control), or placebo, used as a reference in a clinical trial.
▶ Complience. Answer: Adherence to all trial-related requirements, GCP
requirements, and the applicable regulatory requirements.
, ▶ Composite Endpoint. Answer: Overall outcome that the protocol is
designed to evaluate based on more than one common endpoint such as
MI plus repeat intervention.
▶ Compound. Answer: A chemical molecule with potential
pharmacological activity.
▶ Confidentiality. Answer: Prevention of disclosure of a sponsor's
proprietary information or of a subject's identity to unauthorized individuals.
▶ Conformance. Answer: An affirmative indication or judgement that a
product or service has met the requirements of a relevant specification,
contract, or regulation.
▶ Contract. Answer: A written, dated, and signed agreement that sets out
any arrangements on delegation and distribution of tasks and obligations
and, if appropriate, on financial matters between two or more parties.
Protocol may serve as the basis of a contract.
▶ Coordinating Committee. Answer: A committee that a sponsor may
organize to coordinate the conduct of a multi center trial.
▶ Coordinating Investigator. Answer: An investigator assigned the
responsibility for the coordination of investigators at different centers
participating in a multicenter trial.
▶ Contract Research Organization (CRO). Answer: A person or an
organization (commercial, academic, or other) contracted by the sponsor to
perform one or more of a sponsor's trial-related duties and functions.
▶ Control Chart. Answer: A chart with upper and lower control limits on
which values of some statistical measure for a series of samples or
subgroups are plotted. The chart frequently shows a central line to help
detect a trend of plotted values toward either control limit.
▶ Corrective Action. Answer: The implementation of solutions resulting in
the reduction or elimination of an identified problem.
▶ CS. Answer: Clinically Significant
